查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945500

2026年全球莱姆病检测市场报告

Lyme Disease Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，莱姆病检测市场显着扩张，预计将从2025年的106.8亿美元成长到2026年的116.7亿美元，复合年增长率达9.3%。过去几年的成长可归因于莱姆病发病率的上升、早期诊断意识不足、对传统血清学检测的依赖、医院诊断的增加以及蜱传疾病监测技术的进步。

预计未来几年莱姆病检测市场规模将强劲成长，到2030年将达到164.6亿美元，复合年增长率（CAGR）为9.0%。预测期内的成长要素包括人工智慧辅助诊断技术的应用、家用检测套组的广泛普及、多病种检测组合的扩展、政府对蜱传疾病监测投入的增加以及基于云端的检测数据管理的整合。预测期内的主要趋势包括就地检验的扩展、莱姆病居家诊断、多病原体蜱传疾病检测组合、快速检测套组的应用以及个性化诊断通讯协定的製定。

未来几年，由于蜱传疾病发生率的上升，莱姆病检测市场预计将会扩大。蜱传疾病是指透过受感染的蜱虫叮咬传播给人类的一组疾病。蜱虫是一种小型吸血寄生虫，栖息于草原、森林和乡村地区。气候变迁正在推动蜱虫栖息地的扩张，增加感染的风险和盛行率，因此也增加了对蜱传疾病治疗的需求。蜱传疾病是莱姆病的主要传播途径，这推动了对莱姆病检测的需求。早期发现和诊断对于有效控制不断增加的感染病例至关重要。例如，美国疾病管制与预防中心（CDC）于2025年3月发布的数据显示，2023年报告的莱姆病病例数超过89,000例，显示与往年相比，蜱传疾病的负担持续居高不下。因此，蜱传疾病的流行正在推动莱姆病检测市场的扩张。

莱姆病检测市场的公司正致力于诊断工具的技术创新，旨在提高检测准确性、缩短结果交付时间并支持疾病的早期发现。这些诊断工具包括各种设备、试剂盒和技术，它们透过检测与致病菌伯氏疏螺旋体相关的抗体、抗原或遗传物质来识别莱姆病的存在。例如，2024年8月，英国生技公司EpitogenX宣布推出一款新的莱姆病诊断试剂盒。这款基于酵素连结免疫吸附试验（ELISA）的检测方法采用了该公司专有的「Epitogen」平台技术，包含约120种不同的伯氏疏螺旋体表位，具有高特异性和高灵敏度。该试剂盒仅供研究使用（RUO），能够实现早期、菌株特异性检测，并适用于各种实验室环境，有望提高诊断准确性，并为莱姆病的研究提供更深入的见解。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球莱姆病检测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 扩大即时检测范围
    • 在家诊断莱姆病
    • 多病原体蜱性行为感染疾病检测组合
    • 快速检测套组的引入
    • 个性化诊断通讯协定

第五章 终端用户产业市场分析

  • 医院和诊所
  • 诊断检查室
  • 居家医疗环境
  • 研究所
  • 公共卫生机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球莱姆病检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球莱姆病检测市场规模、对比及成长率分析
  • 全球莱姆病检测市场表现：规模与成长，2020-2025年
  • 全球莱姆病检测市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按测试类型
  • 血清学检测、核酸检测、尿液抗原检测和其他类型的检测
  • 采用检查调查方法进行调查的方法
  • 酵素免疫分析法（ELISA）、西方墨点法、聚合酵素链锁反应（PCR）、萤光（IFA）和其他新兴技术
  • 按疾病阶段
  • 早期检测莱姆病、扩散性莱姆病、慢性莱姆病和无症状莱姆病
  • 依检体类型
  • 血液、尿液、脑脊髓液 (CSF) 和其他血液样本
  • 最终用户
  • 医院/诊所、诊断检查室、居家医疗机构、研究实验室、公共卫生机构
  • 按类型细分：血清学检测
  • 酵素免疫分析法、西方墨点法、萤光试验（IFA）、线性免疫检测（LIA）
  • 按类型细分：核酸检测
  • 聚合酵素链锁反应（PCR）、恒温环型核酸扩增扩增（LAMP）、次世代定序（NGS）
  • 依类型细分：尿抗原检测
  • 横向流动化验、酵素免疫分析法(EIA) 和免疫印迹尿液检查
  • 按类型细分：其他检查类型
  • 基于培养的检测、蜱传共感染疾病检测以及人工智慧辅助诊断工具

第十章 区域与国家分析

  • 全球莱姆病检测市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球莱姆病检测市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 莱姆病检测市场：竞争格局及市场占有率（2024年）
  • 莱姆病检测市场：公司估值矩阵
  • 莱姆病检测市场：公司概况
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Labcorp Holdings Inc.
    • Quest Diagnostics Incorporated
    • Eurofins Scientific

第37章：其他领先和创新企业

  • BIOMERIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN NV, DiaSorin SpA, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年莱姆病检测市场：提供新机会的国家
  • 2030年莱姆病检测市场：新兴细分市场机会
  • 莱姆病检测市场展望（2030 年）：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MLDTI04_G26Q1

Lyme disease testing involves diagnostic methods used to identify infection with Borrelia burgdorferi, the bacterium responsible for Lyme disease, which is commonly transmitted via tick bites. The primary goal of Lyme disease testing is to ensure accurate diagnosis, particularly in individuals presenting symptoms such as fever, fatigue, and the distinctive bull's-eye rash.

The primary types of tests used in Lyme disease diagnostics include serological tests, nucleic acid tests, urine antigen tests, and others. Serological tests detect the presence of antibodies or antigens in a patient's blood to determine exposure to infections or immune responses. Common testing techniques include enzyme-linked immunosorbent assay (ELISA), Western blot, polymerase chain reaction (PCR), immunofluorescence assay (IFA), and others. Testing is applicable across different disease stages, including early Lyme disease, disseminated Lyme disease, chronic Lyme disease, and asymptomatic infection detection. Various sample types used include blood, urine, cerebrospinal fluid (CSF), and more. These diagnostic procedures are carried out by a range of end users, such as hospitals and clinics, diagnostic laboratories, home care settings, research institutions, and public health agencies.

Tariffs are impacting the Lyme disease testing market by increasing the cost of imported diagnostic reagents, laboratory equipment, and test kits, especially impacting nucleic acid tests and advanced serological assays. Regions such as North America and Europe, which rely on imported high-end testing equipment, face higher production costs and slower adoption rates. Hospitals, diagnostic laboratories, and research institutions are the most affected segments. On the positive side, tariffs are encouraging local manufacturing and development of cost-effective alternatives, which may reduce dependency on imports over time.

The lyme disease testing market research report is one of a series of new reports from The Business Research Company that provides lyme disease testing market statistics, including lyme disease testing industry global market size, regional shares, competitors with a lyme disease testing market share, detailed lyme disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the lyme disease testing industry. This lyme disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lyme disease testing market size has grown strongly in recent years. It will grow from $10.68 billion in 2025 to $11.67 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising incidence of lyme disease, limited awareness about early diagnosis, reliance on conventional serological testing, increasing hospital-based diagnostics, growing research in tick-borne diseases.

The lyme disease testing market size is expected to see strong growth in the next few years. It will grow to $16.46 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to adoption of ai-assisted diagnostics, growth in home-testing kits, expansion of multi-disease panels, increasing government funding for tick-borne disease surveillance, integration of cloud-based laboratory data management. Major trends in the forecast period include point-of-care testing expansion, home-based lyme disease diagnostics, multi-pathogen tick-borne panels, rapid test kits adoption, personalized diagnostic protocols.

The increasing incidence of tick-borne diseases is anticipated to drive the expansion of the Lyme disease testing market in the coming years. Tick-borne diseases are a group of illnesses transmitted to humans through the bite of infected ticks, which are small, blood-feeding parasites commonly found in grassy, wooded, or rural regions. The growing need for treatments for tick-borne illnesses is driven by the widening geographic distribution of ticks due to climate change, resulting in greater exposure and higher infection rates. Tick-borne diseases fuel the demand for Lyme disease testing because they represent the primary route of Lyme disease transmission, making early detection and diagnosis essential for managing the increasing number of infection cases effectively. For example, in March 2025, the U.S. Centers for Disease Control and Prevention (CDC), a federal public health agency, reported that over 89,000 Lyme disease cases were recorded in 2023, indicating a persistently high burden of tick-borne illnesses compared to prior years. Thus, the growing prevalence of tick-borne diseases is contributing to the expansion of the Lyme disease testing market.

Companies in the Lyme disease testing market are emphasizing technological innovations in diagnostic tools to improve test accuracy, decrease turnaround times, and support early-stage disease detection. These diagnostic tools include devices, kits, and technologies designed to identify the presence of Lyme disease by detecting antibodies, antigens, or genetic material associated with Borrelia burgdorferi, the bacteria responsible for the disease. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, launched a new Lyme Disease Diagnostic Kit. This ELISA-based assay was developed using the company's proprietary EpitoGen platform and includes approximately 120 distinct Borrelia epitopes, offering high specificity and sensitivity. Designed for research use only (RUO), the kit enables early, strain-specific detection and can be adapted for various laboratory settings, providing enhanced diagnostic accuracy and deeper insights into Lyme disease.

In May 2024, T2 Biosystems Inc., a US-based in vitro diagnostics company, formed a partnership with ECO Laboratory to improve early Lyme disease detection. This collaboration focuses on advancing the development and clinical validation of the T2Lyme Panel, a molecular diagnostic test aimed at providing accurate and early detection of Lyme disease. The partnership utilizes ECO Laboratory's CLIA-certified facilities to broaden access to advanced tick-borne disease testing throughout the United States. ECO Laboratory is a US-based diagnostic service provider specializing in Lyme and other tick-borne illnesses.

Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMERIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG, Hologic Inc., Seegene Inc.

North America was the largest region in the lyme disease testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lyme disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lyme disease testing market includes revenues earned by entities by providing services such as diagnostic test kit development, laboratory testing services, polymerase chain reaction (PCR)-based testing, serological testing, and point-of-care testing solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lyme Disease Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lyme disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lyme disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lyme disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Serological Tests; Nucleic Acid Tests; Urine Antigen Tests; Other Test Types
  • 2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA); Weste Blot; Polymerase Chain Reaction (PCR); Immunofluorescence Assay (IFA); Other Emerging Technologies
  • 3) By Disease Stage: Early Lyme Disease; Disseminated Lyme Disease; Chronic Lyme Disease; Asymptomatic Lyme Disease Detection
  • 4) By Sample Type: Blood; Urine; Cerebrospinal Fluid(CSF); Other Blood Samples
  • 5) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Home Care Settings; Research Institutions; Public Health Organizations
  • Subsegments:
  • 1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
  • 2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
  • 3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
  • 4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Labcorp Holdings Inc.; Quest Diagnostics Incorporated; Eurofins Scientific; BIOMERIEUX; Quidel Corporation; Bio Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A; Meridian Bioscience; Trinity Biotech; T2 Biosystems; IGeneX; Viramed Biotech AG; Ceres Nanosciences; Galaxy Diagnostics; Lyme Diagnostics Ltd; Abbott Laboratories; Siemens Healthineers AG; Hologic Inc.; Seegene Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Lyme Disease Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Lyme Disease Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Lyme Disease Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Lyme Disease Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Point-Of-Care Testing Expansion
    • 4.2.2 Home-Based Lyme Disease Diagnostics
    • 4.2.3 Multi-Pathogen Tick-Borne Panels
    • 4.2.4 Rapid Test Kits Adoption
    • 4.2.5 Personalized Diagnostic Protocols

5. Lyme Disease Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Home Care Settings
  • 5.4 Research Institutions
  • 5.5 Public Health Organizations

6. Lyme Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lyme Disease Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Lyme Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Lyme Disease Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Lyme Disease Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Lyme Disease Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lyme Disease Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lyme Disease Testing Market Segmentation

  • 9.1. Global Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types
  • 9.2. Global Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies
  • 9.3. Global Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection
  • 9.4. Global Lyme Disease Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Urine, Cerebrospinal Fluid (CSF), Other Blood Samples
  • 9.5. Global Lyme Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations
  • 9.6. Global Lyme Disease Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
  • 9.7. Global Lyme Disease Testing Market, Sub-Segmentation Of Nucleic Acid Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
  • 9.8. Global Lyme Disease Testing Market, Sub-Segmentation Of Urine Antigen Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
  • 9.9. Global Lyme Disease Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

10. Lyme Disease Testing Market Regional And Country Analysis

  • 10.1. Global Lyme Disease Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Lyme Disease Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lyme Disease Testing Market

  • 11.1. Asia-Pacific Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lyme Disease Testing Market

  • 12.1. China Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lyme Disease Testing Market

  • 13.1. India Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lyme Disease Testing Market

  • 14.1. Japan Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lyme Disease Testing Market

  • 15.1. Australia Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lyme Disease Testing Market

  • 16.1. Indonesia Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lyme Disease Testing Market

  • 17.1. South Korea Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lyme Disease Testing Market

  • 18.1. Taiwan Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lyme Disease Testing Market

  • 19.1. South East Asia Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lyme Disease Testing Market

  • 20.1. Western Europe Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lyme Disease Testing Market

  • 21.1. UK Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lyme Disease Testing Market

  • 22.1. Germany Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lyme Disease Testing Market

  • 23.1. France Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lyme Disease Testing Market

  • 24.1. Italy Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lyme Disease Testing Market

  • 25.1. Spain Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lyme Disease Testing Market

  • 26.1. Eastern Europe Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lyme Disease Testing Market

  • 27.1. Russia Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lyme Disease Testing Market

  • 28.1. North America Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lyme Disease Testing Market

  • 29.1. USA Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lyme Disease Testing Market

  • 30.1. Canada Lyme Disease Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lyme Disease Testing Market

  • 31.1. South America Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lyme Disease Testing Market

  • 32.1. Brazil Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lyme Disease Testing Market

  • 33.1. Middle East Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lyme Disease Testing Market

  • 34.1. Africa Lyme Disease Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Lyme Disease Testing Market, Segmentation By Test Type, Segmentation By Testing Methodology, Segmentation By Disease Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lyme Disease Testing Market Regulatory and Investment Landscape

36. Lyme Disease Testing Market Competitive Landscape And Company Profiles

  • 36.1. Lyme Disease Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Lyme Disease Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Lyme Disease Testing Market Company Profiles
    • 36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

37. Lyme Disease Testing Market Other Major And Innovative Companies

  • BIOMERIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG

38. Global Lyme Disease Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lyme Disease Testing Market

40. Lyme Disease Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Lyme Disease Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Lyme Disease Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Lyme Disease Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer